Infantile spasms, also known as West syndrome, is a rare but severe form of epilepsy that typically begins in the first year ...

Researchers found that the vertebrae of horses with PPID had significantly lower bone-mineral density compared to those of ...

While much of the focus remains on its impact on neurophysiological processes, there is growing curiosity about its broader implications across diverse biological systems. This article aims to explore ...

Fetal growth restriction (FGR) is defined as a pathological in utero growth disorder primarily caused by factors related to ...

An Adrenocorticotropic hormone (ACTH) stimulation test was performed and showed no cortisol present, with or without ...

It is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing’s disease.

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for paltusotine, the first once-daily, oral ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) ...

在宝鸡市中医医院内分泌科，接诊的金安林副主任根据常女士出现的典型“满月脸”、“水牛背”、“面部粗糙”等临床症状，安排了一系列专业细致的检查，提示其促肾上腺皮质激素 (ACTH)明显增高，垂体核磁共振 ...

圣地亚哥 - Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) 已向美国食品和药物管理局（FDA）提交了paltusotine的新药申请（NDA）。Paltusotine是一种针对肢端肥大症的新型治疗选择。这种药物是每日一次的口服疗法，专门针对2型生长抑素受体，这一点很重要，因为它为目前作为标准治疗的注射疗法提供了潜在的替代选择。

景迈山的这1年和1300年 共生与传承 ...

The hypothalamus secretes corticotropin releasing factor, which acts on the anterior pituitary, where it stimulates the secretion of adrenocorticotropin (ACTH). The adrenal glands are stimulated ...